Deals

Cases

SOON

News

Moves

The Sponsor

Loading page...

Stay informed with the latest news and developments in the legal industry. Explore profiles of top law firms and their talented professionals. Empowering the legal community with real-time insights and comprehensive firm profiles.

Directories

Deals

News

Moves

Firms

Account

Profile

SOON

Sign in

SOON

Analysis

AI Rankings

Deal Activity

Salaries

SOON

Firm Comparison

SOON

© The Sponsor. All rights reserved.

Terms & Conditions | Privacy Policy

Sophia Hudson, P.C. Profile, Deals & Rankings | The Sponsor - The Sponsor

Kirkland & Ellis LLP

Sophia Hudson, P.C.

Sophia Hudson, P.C.

Qualified in New York (US), 2007

Partner for 7 years

Practice Areas

Capital Markets

SEC Compliance

Mergers & Acquisitions

Restructurings

Professional Bio

Sophia Hudson, P.C., is a distinguished partner at Kirkland & Ellis LLP, based in New York. She leads the firm's global Capital Markets Practice Group, providing expert counsel on a wide range of capital markets transactions, including IPOs, equity offerings, and debt placements. Sophia is renowned for her commercial acumen and technical proficiency, advising both public companies and private equity sponsors. Her practice areas include Capital Markets, SEC Compliance, and Mergers & Acquisitions. Sophia's client roster features prominent names such as Bain Capital, Bristol Myers Squibb, and United Airlines. She holds a JD from the University of Michigan Law School and an AB in History from Princeton University.

Kirkland & Ellis LLP

New York

+12124464800

Representative Matters

Mergers & Acquisitions and Public Offerings

AbbVie in its $63 billion acquisition of Allergan and the related $30 billion senior notes offering.
Bristol Myers Squibb in its $90 billion acquisition of Celgene, $19 billion offering of senior notes to fund the acquisition, and $18.1 billion combined acquisition of Karuna Therapeutics and RayzeBio.
Eli Lilly and Company in its $2.4 billion acquisition of DICE Therapeutics, Inc., and $610 million acquisition of Akouos.

Debt Financings and Offerings

Anywhere Real Estate in its $640 million offering of senior notes.
Affimed in multiple follow-on offerings of common stock totaling ~$200 million, and in the establishment of an "At-the-Market" sales program.
Apax Partners and Warburg Pincus in the sale of $2.075 billion of senior notes to fund the $3.4 billion buy-out of Inmarsat.
Awilhelmsen in its sale of more than $550 million of common stock of Royal Caribbean Cruises.
Bed Bath & Beyond on a series of complex financing transactions, including an underwritten public offering of equity derivatives securities of $225 million.

Strategic Investments and Partnerships

Montes Archimedes Acquisition Corp. a SPAC sponsored by Patient Square Capital, in its $400 million IPO and subsequent $7.3 billion business combination with Roivant Sciences.
Patient Square Capital in its acquisitions, including the $7.1 billion take-private of Syneos Health, Inc.
Pharvaris in its "at-the-market" offering program of $75 million of common shares and $70 million PIPE offering.

Restructurings and Liability Management

Intelsat in its debt restructuring and in connection with its Chapter 11 bankruptcy.
J.C. Penney in its debt restructuring and Chapter 11 bankruptcy.
Norwegian Cruise Line in multiple liability management transactions totaling $2.25 billion, consisting of offerings of exchangeable senior notes and common equity.

gradient

Deal Summary

0

Deals

$0.0

Total Value

Clients Worked With

AcordaAffimedAnywhere Real EstateApax PartnersAssociated MaterialsAwilhelmsenBain CapitalBCLS Acquisition CorpBed Bath & BeyondBrandSafwayBristol Myers SquibbBristol-Myers SquibbCarlisle CompaniesCenterbridge PartnersColfaxConstellation BrandsDelphi TechnologiesEli Lilly and Co.Eli Lilly and CompanyEvotecFergusonFoxHuntsman InternationalInflaRXIntelsatJ.C. PenneyKPS Capital PartnersLLamasoftMetromileMontes Archimedes Acquisition CorpMontes Archimedes Acquisition Corp.NortonLifeLockNorwegian Cruise LineParthenon Capital Partners-backed loanDepotPatient Square CapitalPharvarisPike Corp.Rocket SoftwareRootSVB LeerinkTPG CapitalTPG Real Estate Finance TrustTransplace Inc.Tupperware BrandsUnisysUnited AirlinesViagogoWeWorkAbbVie

Related Deals

Kirkland & Ellis LLP

Kirkland & Ellis advises Amicus Therapeutics on $4.8 billion sale to BioMarin

- Kirkland & Ellis advised Amicus Therapeutics (Nasdaq: FOLD) on its agreed all-cash sale to BioMarin (Nasdaq: BMRN) at $14.50 per share, valuing Amicus at about $4.8bn. - The deal was unanimously approved by both boards, with Amicus’ board recommending stockholders vote in favour; expected to close in Q2 2026, subject to regulatory and Amicus stockholder approvals and other customary conditions. - The acquisition adds Galafold (Fabry) and Pombiliti + Opfolda (Pompe) to BioMarin’s lysosomal storage disorder portfolio, and includes Amicus’ U.S. rights to DMX-200 (Phase 3) for FSGS.

Dec 19 2025

5B

M&A

Related News

Kirkland Represents MultiPlan Corporation in Comprehensive Refinancing

Kirkland Represents MultiPlan Corporation in Comprehensive Refinancing

Kirkland & Ellis is advising MultiPlan Corporation (NYSE: MPLN), a leading provider of healthcare technology and data solutions, in a comprehensive refinancing to extend the maturities of its entire debt capital structure, which was announced on December 24, 2024. MultiPlan has entered into an agreement with certain ad hoc groups of noteholders and lenders collectively owning approximately 78% of MultiPlan’s outstanding debt to execute a series of transactions to support the company’s Vision 2030 transformation plan. The transactions are expected to comprehensively reorganize MultiPlan’s capital structure and position the company for more sustainable long-term growth. Read MultiPlan’s press release The Kirkland team includes debt finance lawyers David Nemecek, Austin Glassman, Scott Rolnik, Andrew Won and Shelby Nicole Lindholm; capital markets lawyers Julia Danforth, Sophia Hudson, Katherine Shaia, Ashley Sinclair, Soo Kyung Chae, Jihao Ding and Caleb Pilukas; tax lawyers Thad Davis and Matt Advani; and restructuring lawyers Chris Greco, Derek Hunter and Oliver Paré.

Dec 26

Experience

Kirkland & Ellis

Kirkland & Ellis

Partner
2018 – Unknown

D

Davis Polk

Partner
2016 – 2018

Education

JD, University of Michigan Law School
2006

Kirkland & Ellis LLP

Kirkland & Ellis advises Bristol Myers Squibb on $5.5 billion senior notes offering and $7.5 billion tender offer

- Bristol Myers Squibb entered into a financing in Europe on a date not available. - Deal value was 4700000000 Sector: Pharmaceuticals; Location: Europe. - On the acquirer side, counsel was not available, led by Sophia Hudson, Asher Qazi, Parker Davis, Lune Klappe-Regan, Richard Hong, Saud Alshaikh, Basit Khan Bangash, Sara Zablotney, Vivek Ratnam, Yewande Ford, Margot Solmssen, Phil Giglio.

Nov 21 2025

5B

Finance

Kirkland & Ellis LLP

Kirkland & Ellis advises Patient Square Capital on $2.6 billion acquisition of Premier, Inc.

- Patient Square Capital acquired the target/assets from Premier, Inc. in a acquisition on not available. - Deal value was 2600000000 Sector: Healthcare; Location: USA. - On the acquirer side, counsel was not available, led by Maggie Flores, Daniel Wolf, Zach Miller, Ned Schultheis, Michael Weisser, Jason Kanner, Andrea Weintraub, Andrew Hurley, Julia Class, Sophia Hudson, Julia Danforth, Katherine Shaia, Mark Schwed, Rohit Nafday, Anthony Ji.

Sep 22 2025

3B

Private Equity

Kirkland & Ellis LLP

Kirkland & Ellis advises Norwegian Cruise Line on $3.54 billion capital markets transactions

- Norwegian Cruise Line Holdings Ltd. entered into a financing in the USA; seller not available; date not available. - Deal value was 2000000000 Sector: Travel & Leisure; Location: USA. - On the acquirer side, law firm not available advised, led by Zoey Hitzert, Sophia Hudson, Soo Kyung Chae, Lune Klappe, Mary Aertker, Richard Hong, Camille Ciolino, Connor Dalton, Michael Scheinthal, Ben Schreiner, Afshin Khan.

Sep 22 2025

2B

Finance

Kirkland & Ellis LLP

Gibson Dunn

Kirkland & Ellis advises Zebra Technologies on its $1.3 billion acquisition of Elo Touch Solutions, with Gibson Dunn advising Elo Touch Solutions.

- Zebra Technologies Corporation acquired the target/assets from Elo Touch Solutions, Inc. in a acquisition on 2025-08-05. - Deal value was 13000000000 (source: Extracted) Sector: Technology; Location: USA. - On the acquirer side, Kirkland & Ellis advised, led by Laura Sullivan, Alix Simnock, Kevin Akrong.

Aug 05 2025

1B

M&A

Kirkland & Ellis LLP

Kirkland & Ellis advises Bain Capital on strategic investment in PCI Pharma Services

- Bain Capital acquired the target/assets from not available in a Private Equity transaction on not available. - Deal value was 2100000000 Sector: Healthcare; Location: USA. - On the acquirer side, not available advised, led by Chris Elder, Ziyad Ziyadzade, Matthew O'Brien, Ben Vizvary, Yuli Wang, Melissa Hutson, Dan Clayman, Sophia Hudson, Julia Danforth, Mike Carew, Polina Liberman, Dennis Williams, Will Richmond, Vlad Khodosh, Todd Herst, Alexandra Mihalas, R.D. Kohut, Madeline Klebanov, Scott Price, Karsten Busby, Michael Saretsky, Rob Miceli, Abbey Raish, Matt Reilly, Rich Cunningham, Michael Thorpe.

Jul 14 2025

2B

Private Equity

1 min

Kirkland Advises Bain Capital-Backed Rocket Software on Acquisition of Vertica Analytics Database Platform from OpenText

Kirkland Advises Bain Capital-Backed Rocket Software on Acquisition of Vertica Analytics Database Platform from OpenText

Kirkland & Ellis advised Rocket Software, a Bain Capital Private Equity portfolio company and global technology leader in modernization software, on its definitive agreement to acquire the Vertica analytics database from OpenText (Nasdaq: OTEX) (TSX: OTEX). This acquisition accelerates Rocket Software’s strategy to be the partner of choice for modernization without disruption, allowing customers not only to modernize core systems and data but also to run next-generation analytics and GenAI directly on that trusted data. The transaction is expected to close in the middle of calendar year 2026, subject to receipt of applicable regulatory approvals and other customary closing conditions. Read Rocket Software’s press release The Kirkland team included corporate lawyers Chris Elder, Zoe Quick, Matthew O’Brien, Josh Dubin and Namjun Park; technology & IP transactions lawyers Martin Schwertmann, Derek Ventling and Vlad Khodosh; tax lawyers Polina Liberman, Mike Carew and Alan Walker; capital markets lawyers Sophia Hudson and Sarah Lipinski; debt finance lawyers Andrew Idrizovic and Matt Stummer; executive compensation lawyers Scott Price and Sally Ye; employment & labor lawyers R.D. Kohut and Madeline Klebanov; employee benefits lawyer Alexandra Mihalas; antitrust & competition lawyers Rich Cunningham, Colin Herd, Andris Rimsa and Athina Van Melkebeke; environmental transactions lawyer Michelle Sliwinski DeMaio; real estate lawyer John Caruso; international trade & national security lawyer John Kabealo; and government contracts lawyer Rob Ryland.

Feb 4

1 min

Kirkland Advises Patient Square on $4.1 Billion Acquisition of Patterson Companies

Kirkland Advises Patient Square on $4.1 Billion Acquisition of Patterson Companies

Kirkland & Ellis is advising Patient Square, a dedicated health investment firm, on the $4.1 billion acquisition of Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor. A definitive agreement was announced December 11, 2024, and the transaction is expected to close in the fourth quarter of Patterson’s fiscal 2025, subject to the receipt of shareholder approval, regulatory approvals and customary closing conditions. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar day volume-weighted average price ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives). Read the transaction press release The Kirkland team included corporate lawyers Maggie Flores, Michael Weisser and Oliver Yee; debt finance lawyers John Ilardo, Jason Kanner and Joel Weinberger; capital markets lawyers Julia Danforth and Sophia Hudson; and tax lawyer Mark Schwed.

Dec 11

1 min

Kirkland Advises Ziff Davis on $1.2 Billion Sale of Connectivity Division to Accenture

Kirkland Advises Ziff Davis on $1.2 Billion Sale of Connectivity Division to Accenture

Kirkland & Ells advised Ziff Davis, Inc. (Nasdaq: ZD) on a definitive agreement to sell its Connectivity division to Accenture (NYSE: ACN) for $1.2 billion in cash. Ziff Davis’ Connectivity brands are globally recognized in fixed broadband, mobile and Wi-Fi network design, intelligence, insights, testing and incident detection. These brands, including Ookla, Speedtest, Ekahau, Downdetector and RootMetrics, empower organizations to optimize networks, elevate digital experiences and ensure faster, more reliable connectivity. The transaction is currently expected to close in the coming months, subject to the satisfaction of certain closing conditions and receipt of required regulatory approvals. Read the transaction press release The Kirkland team included corporate lawyers David Klein, Andrew Norwich and Daniel Wolf; tax lawyer Sara Zablotney; executive compensation lawyer Rob Fowler; capital markets lawyers Sophia Hudson and Zoey Hitzert; antitrust & competition lawyer Daniel Zach; and technology & IP transactions lawyer Daisy Darvall.

Mar 3

1 min

Kirkland Advises Gen Digital on Acquisition of MoneyLion for $1 Billion Plus CVR

Kirkland Advises Gen Digital on Acquisition of MoneyLion for $1 Billion Plus CVR

Kirkland & Ellis is advising Gen Digital Inc. (NASDAQ: GEN), a company dedicated to powering Digital Freedom through its family of consumer brands, on the acquisition of MoneyLion Inc. (NYSE: ML), a leading digital ecosystem for consumer finance. The companies announced a definitive agreement on December 10, 2024, and the transaction is expected to close in the first half of Gen’s fiscal year 2026 subject to customary closing conditions. The deal includes $82.00 per share in cash payable at closing, representing a cash value of approximately $1 billion. In addition, for each share owned, MoneyLion shareholders will receive at closing one contingent value right (CVR) that entitles the holder to a contingent payment of $23.00 in the form of shares of Gen common stock (issuable based on an assumed share price of $30.48 per Gen share) if Gen’s average volume-weighted average share price reaches at least $37.50 per share over 30 consecutive trading days from December 10, 2024 until 24 months after close. Read the transaction press release The Kirkland team included corporate lawyers Edward Lee, Carlo Zenkner, Dan Li and Alex Adamis; executive compensation lawyers Rohit Nafday, Anthony Ji and Devin Kern; capital markets lawyers Sophia Hudson, Jennifer Lee, Leia Andrew and Chi Vo Kavanaugh; tax lawyers Sara Zablotney, Maria Smith and Matthew Buono; structured finance lawyers Joel Weinberger and John Harrison; litigation lawyers Stefan Atkinson, Paige Comparato and Christopher Leach; and investment funds lawyers Daniel Kahl, Xiao-Hong Jing and Lena Yoon.

Dec 10

1 min

Kirkland Represents Bain Capital in Investment in Defense Unicorns

Kirkland Represents Bain Capital in Investment in Defense Unicorns

Kirkland & Ellis advised Bain Capital Tech Opportunities on its Series B funding in Defense Unicorns, a leader in airgap software delivery for national security mission systems. The investment brings the company to unicorn status with a valuation exceeding $1 billion, driven by the company's rapid and profitable growth. The new capital will enable Defense Unicorns to further scale and integrate open-source and commercial dual-use technology throughout the U.S. military and allied forces. Read Bain Capital’s press release The Kirkland team included corporate lawyers Chris Elder, Kendahl Mordini, Matthew O’Brien, Luv Karia and Millie Ball; tax lawyers Mike Carew and David Gilbert; capital markets lawyers Sophia Hudson and Sarah Lipinski; technology & IP transactions lawyers Dan Lewis and Jackson Zebovitz; litigation lawyer Nick Niles; executive compensation lawyers Scott Price, Kelsie Harris and Shyion Byfield; employment & labor lawyers R.D. Kohut, Madeline Klebanov and Jon Link; employee benefits lawyers Alexandra Mihalas and Daniel Coleman; government contracts lawyers Rob Ryland and Dana Diaz; and international trade & national security lawyers Ivan Schlager, Justin Campbell and Chad Crowell; sustainability lawyers Abbey Raish and Annah Akhoun-Murat.

Jan 14

1 min

...

AB in History, Princeton University

2000